Välkommen till Via TT - det enkla pressverktyget

Örebroforskare har testat ett nytt läkemedel mot sepsis. Resultaten visar att det kan skydda mot blodproppar utan att öka risken för blödningar. Nyckeln är Apta-1, en avancerad RNA-molekyl. – Detta är en lovande läkemedelsmekanism för framtida behandlingar av allvarliga sjukdomar, säger professor Magnus Grenegård.

A large proportion of babies born very early need intensive care, which can be painful. But the healthcare system fails to provide pain relief to the full extent. This is shown by the largest survey to date of pain in neonatal care, now published in the journal Pain.

Andernach – LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company, is proud to announces its selection as a Concept Stage winner for two projects in the #PatchForwardPrize, a $50 million challenge by the Biomedical Advanced Research and Development Authority (BARDA) to advance microneedle patch-based RNA vaccine technologies. The Patch Forward Prize, part of the Project NextGen initiative led by BARDA, aims to accelerate next-generation vaccine technologies. By fostering partnerships between vaccine developers and delivery platform innovators, the competition drives progress from concept to clinical stages, paving the way for transformative advancements in global health. Each of the prizes announced today represents an award of US$ 2 million, that will be shared between LTS and its partners. The awarded projects bring together LTS’s proprietary dissolvable Microneedle Array Patch (MAP) technology with mRNA vaccines from two partners, BioNet, a biotech man

As part of the EU-funded APRIORA project, drug residues are being analysed. Scientists from the University of Rostock are taking water samples in all weathers. The aim is to use innovative approaches to improve wastewater treatment in Europe.

Market proximity of Strides Pharma International AG, based in Zug, Switzerland, opens the way for rapid technology transfer and innovation within the European market Oren Weininger, longstanding leader at Fairmed Healthcare, heads the business as CEO and Chairman of the Board

Aleris onkologiklinik på Sabbatsbergs sjukhus utökar tillgången till innovativ skalpkylbehandling för cancerpatienter efter ett framgångsrikt pilotprojekt tillsammans med Dignitana.

The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures per year in the U.S.[2] QUTENZA® is a topical system, non-systemic, non-opioid pain treatment that is currently approved in the US for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet in adults. Topline results are expected in Q4 2025 and Averitas Pharma aims to submit a supplemental new drug application (sNDA) for a US label extension in 2026, subject to positive data.

Flera kilo beslagtagen narkotika, beslag och utmätt gods för 800 000 Euro och 57 gripna personer. Det är några resultat av en svenskledd europeisk insats mot gränsöverskridande brottslighet i Östersjöområdet.

Konsumtionen av olagliga cigaretter i Sverige minskade under 2023 men uppgår fortfarande till 7% av den totala konsumtionen under 2023. Det visar en rapport som KPMG gjort på uppdrag av Philip Morris International.

Ett omfattande nätverk med centraler för distribution av narkotika har avslöjats av Tullverket. I flera lägenheter i Stockholmsområdet har ett kriminellt nätverk ägnat sig åt att ta emot beställningar, förpacka och sedan distribuera narkotiska preparat till tusentals drogköpare runt om i Sverige. Nio personer åtalades på fredagen vid Södertörns tingsrätt misstänkta för bland annat synnerligen grovt narkotikabrott.

The risk of skin cancer for adults under the age of 50 is now decreasing for the first time in Sweden, according to a study from Karolinska Institutet published in JAMA Dermatology.

Nu integreras Swedish Match och Philip Morris i Sverige under varumärket Swedish Match. Det här är ett betydande steg i den integration som pågått sedan det amerikanska tobaksbolaget Philip Morris International 2022 förvärvade Swedish Match med en bred portfölj av av snus och nikotinportioner.

In a recent study published in Nature, Swedish researchers demonstrate the role of sex hormones in regulating the immune system. This newfound knowledge explains differences between men and women and can be used to develop new immunological medications according to researchers.

Tübingen, Germany, August 12, 2024 Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR clinical study at the HansonWade 4th Inner Ear Disorders Therapeutics Summit in Boston (MA) from August 20–22, and at the 36th World Congress of Audiology from September 19–22, 2024.

Researchers at Karolinska Institutet may have found a new way to treat obesity and related disorders by targeting the cells’ powerhouses, the mitochondria. A study published in Nature Metabolism shows that a specific class of drugs that block mitochondrial function can reverse diet-induced obesity, fatty liver and diabetes in mice.

Plans to use innovative Bosch BioMEMS technology in PCR tests for multiresistant bacteria

The launch in Germany through its step-down subsidiary betapharm marks Dr. Reddy's entry into digital therapeutics in Europe. Nerivio® is the first REN (wearable, FDA-cleared, and CE-marked for acute and/or prevention migraine (with or without aura) treatment for adults and adolescents (≥ 12 years). Nerivio® is worn on the upper arm during treatment and controlled by a smartphone app, making it comfortable and portable. Starting with Germany, followed by Spain and the UK, Dr. Reddy's plans to further increase access to Nerivio® in European countries.

Psykiatriska diagnoser som adhd, missbruk och depression ökar risken för unga att begå brott – särskilt för kvinnor. Det visar Rebecca Siponens avhandling i kriminologi vid Örebro universitet. – Det här är kunskap som kan användas för att hindra unga från att involveras i allvarlig brottslighet, säger hon.

Half of all patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily. This is according to a new study published in the New England Journal of Medicine. "I am convinced that this will influence future practice", says Tomas Jernberg, Professor at Karolinska Institutet and lead researcher of the study.

Under 2023 besvarade Giftinformationscentralens telefonrådgivning mer än 108 000 frågor om akuta förgiftningar. Förfrågningarna från sjukvården har ökat mest, särskilt nattetid.